View More View Less
  • 1 Department of Microbiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
  • | 2 Razi Clinical Research Development Unit, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran
  • | 3 Clinical Research Development Unit of Poursina Hospital, Guilan University of Medical Sciences, Rasht, Iran
  • | 4 Department of Biostatistics, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Abstract

This study was aimed to evaluate occurrence of antibiotic resistance and the presence of resistance determinants among clinical isolates of Acinetobacter baumannii. This cross-sectional study from January to September 2018 was performed on 59 A. baumannii strains isolated from clinical samples in the north of Iran. Isolates were identified by standard microbiologic tests and molecular method. Antimicrobial susceptibility testing was carried out by disk diffusion and broth microdilution methods. The presence of carbapenem resistance genes was detected by PCR method. All isolates were resistant to cefepime, meropenem, imipenem and ceftazidime. The lowest resistance rate was observed against doxycycline with 33.9%. Minimum inhibitory concentration (MIC) results showed that all carbapenem-resistant A. baumannii (CRAB) isolates were susceptible to colistin with MIC50 and MIC90 values of 1/2 µg/mL. Among 59 CRAB, bla OXA-23-like was the most prevalent gene (86.4%) followed by bla OXA-24-like (69.5%). Meanwhile, none of the clinical isolates harbored bla OXA-58-like gene. We found a high prevalence of CRAB strains harboring OXA-type carbapenemases in the north of Iran. Our results suggests that the presence of OXA-type genes was not directly correlated with the increase of imipenem MIC level, but can be clinically important as they contribute to the selection of CRAB strains.

  • [1]

    Alsan M, Klompas M. Acinetobacter baumannii: an emerging and important pathogen. J Clin Outcomes Manag 2010; 17: 363369.

  • [2]

    Jahangiri S, Malekzadegan Y, Motamedifar M, Hadi N. Virulence genes profile and biofilm formation ability of Acinetobacter baumannii strains isolated from inpatients of a tertiary care hospital in southwest of Iran. Gene Reports 2019; 17.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [3]

    Al-Anazi KA, Al-Jasser AM. Infections caused by Acinetobacter baumannii in recipients of hematopoietic stem cell transplantation. Front Oncol 2014; 4: 186.

    • Search Google Scholar
    • Export Citation
  • [4]

    Gonzalez-Villoria AM, Valverde-Garduno V. Antibiotic-resistant Acinetobacter baumannii increasing success remains a challenge as a nosocomial pathogen. J Pathog 2016; 2016: 7318075.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [5]

    Soltani B, Heidari H, Ebrahim-Saraie HS, Hadi N, Mardaneh J, Motamedifar M. Molecular characteristics of multiple and extensive drug-resistant Acinetobacter baumannii isolates obtained from hospitalized patients in Southwestern Iran. Infez Med 2018; 26: 6776.

    • Search Google Scholar
    • Export Citation
  • [6]

    Kattan JN, Villegas MV, Quinn JP. New developments in carbapenems. Clin Microbiol Infect 2008; 14: 11021111.

  • [7]

    Nasiri MJ, Zamani S, Fardsanei F, Arshadi M, Bigverdi R, Hajikhani B, et al. Prevalence and mechanisms of carbapenem resistance in Acinetobacter baumannii: a comprehensive systematic review of cross-sectional studies from Iran. Microb Drug Resist 2019.

    • Search Google Scholar
    • Export Citation
  • [8]

    Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826836.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [9]

    Evans BA, Amyes SG. OXA beta-lactamases. Clin Microbiol Rev 2014; 27: 241263.

  • [10]

    Malekzadegan Y, Abdi A, Heidari H, Moradi M, Rastegar E, Sedigh Ebrahim-Saraie H. In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran. BMC Res Notes 2019; 12: 301.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [11]

    Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 2017; 30: 557596.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [12]

    Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of infections due to MDR gram-negative bacteria. Front Med (Lausanne) 2019; 6: 74.

  • [13]

    Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27: 351353.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [14]

    CLSI. Performance standards for antimicrobial susceptibility testing; 28th informational supplement. CLSI document M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018. [2018].

    • Search Google Scholar
    • Export Citation
  • [15]

    Matuschek E, Ahman J, Webster C, Kahlmeter G. Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter spp. Clin Microbiol Infect 2018; 24: 865870.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [16]

    Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268281.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [17]

    Nobari S, Shahcheraghi F, Rahmati Ghezelgeh F, Valizadeh B. Molecular characterization of carbapenem-resistant strains of Klebsiella pneumoniae isolated from Iranian patients: first identification of blaKPC gene in Iran. Microb Drug Resist 2014; 20: 285293.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [18]

    Esfandiari A, Rashidian A, Masoumi Asl H, Rahimi Foroushani A, Salari H, Akbari Sari A. Prevention and control of health care-associated infections in Iran: a qualitative study to explore challenges and barriers. Am J Infect Control 2016; 44: 11491153.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [19]

    Zowawi HM, Sartor AL, Sidjabat HE, Balkhy HH, Walsh TR, Al Johani SM, et al. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers. J Clin Microbiol 2015; 53: 896903.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [20]

    Rocha L, Pagano M, Campos JC, Sampaio JLM, Martins AF, Barth AL. Carbapenem-resistant Acinetobacter baumannii in Brazil: susceptibility profile and diversity of oxacillinases. J Bras Patol Med Lab 2017; 53: 358361.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [21]

    Ahmed SS, Alp E, Ulu-Kilic A, Dinc G, Aktas Z, Ada B, et al. Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study. Eur J Clin Microbiol Infect Dis 2016; 35: 14631468.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [22]

    Wu W, He Y, Lu J, Lu Y, Wu J, Liu Y. Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii clinical isolates in Southern China: an 8-year study. PLoS One 2015; 10: e0137174.

    • Search Google Scholar
    • Export Citation
  • [23]

    Zhang Y, Li Z, He X, Ding F, Wu W, Luo Y, et al. Overproduction of efflux pumps caused reduced susceptibility to carbapenem under consecutive imipenem-selected stress in Acinetobacter baumannii. Infect Drug Resist 2017; 11: 457467.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [24]

    Coyne S, Courvalin P, Perichon B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 2011; 55: 947953.

  • [25]

    Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006; 258: 7277.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [26]

    Viana GF, Zago MC, Moreira RR, Zarpellon MN, Menegucci TC, Cardoso CL, et al. ISAba1/blaOXA-23: a serious obstacle to controlling the spread and treatment of Acinetobacter baumannii strains. Am J Infect Control 2016; 44: 593595.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [27]

    Hua X, Shu J, Ruan Z, Yu Y, Feng Y. Multiplication of blaOXA-23 is common in clinical Acinetobacter baumannii, but does not enhance carbapenem resistance. J Antimicrob Chemother 2016; 71: 33813385.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [28]

    Carvalho KR, Carvalho-Assef APDA, Santos LGd, Pereira MJF, Asensi MD. Occurrence of blaOXA-23 gene in imipenem-susceptible Acinetobacter baumannii. Mem Inst Oswaldo Cruz 2011; 106: 505506.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [29]

    Kheshti R, Pourabbas B, Mosayebi M, Vazin A. In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran. Infect Drug Resist 2019; 12: 129135.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [30]

    Walkty A, DeCorby M, Nichol K, Karlowsky JA, Hoban DJ, Zhanel GG. In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007–2008. Antimicrob Agents Chemother 2009; 53: 49244926.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • [31]

    Gales AC, Seifert H, Gur D, Castanheira M, Jones RN, Sader HS. Antimicrobial susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii complex and Stenotrophomonas maltophilia clinical isolates: results from the SENTRY antimicrobial surveillance program (1997–2016). Open Forum Infect Dis 2019; 6: S34S46.

    • Crossref
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 191 191 7
Full Text Views 29 29 1
PDF Downloads 22 22 1